Innate Pharma S.A. (IPHA)

Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of $198.87 million as of April 26, 2024. Its market cap has decreased by -22.83% in one year.

• Market Cap: 198.87M
• Enterprise Value: 138.69M
• 1-Year Change: -22.83%
• Ranking: #3650
• Category: Micro-Cap
• Stock Price: $2.27

Market Cap Chart

Since October 18, 2019, Innate Pharma's market cap has decreased from $458.70M to $198.87M, a decrease of -56.64%. That is a compound annual growth rate of -16.88%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	197.90M	3.78%
Apr 23, 2024	190.70M	-2.26%
Apr 22, 2024	195.10M	-0.61%
Apr 19, 2024	196.30M	3.81%
Apr 18, 2024	189.10M	-2.48%
Apr 17, 2024	193.90M	-6.96%
Apr 16, 2024	208.40M	7.04%
Apr 15, 2024	194.70M	-2.41%
Apr 12, 2024	199.50M	-
Apr 11, 2024	199.50M	-1.58%
Apr 10, 2024	202.70M	-3.11%
Apr 9, 2024	209.20M	-
Apr 8, 2024	209.20M	2.65%
Apr 5, 2024	203.80M	1.34%
Apr 4, 2024	201.10M	-2.80%
Apr 3, 2024	206.90M	1.97%
Apr 2, 2024	202.90M	-5.98%
Apr 1, 2024	215.80M	-6.94%
Mar 28, 2024	231.90M	21.03%
Mar 27, 2024	191.60M	-2.49%
Mar 26, 2024	196.50M	1.71%
Mar 25, 2024	193.20M	1.10%
Mar 22, 2024	191.10M	-1.49%
Mar 21, 2024	194.00M	-3.63%
Mar 20, 2024	201.30M	2.86%

View and export this data all the way back to 2019. Sign Up Today.

Related Stocks

Company	Market Cap
Rigel Pharmaceuticals	199.93M
Zevra Therapeutics	198.89M
Lifecore Biomedical	197.03M
Trevi Therapeutics	196.54M
Compass Therapeutics	193.78M
Semler Scientific	190.47M
Acumen Pharmaceuticals	189.85M
Profound Medical	188.10M